Opinion
Video
Author(s):
Expert perspectives on treatment options available for patients with bladder cancer and the role of trimodal therapy.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
From BCG shortage to scientific surge: Inside the NMIBC treatment renaissance
Dr. Schwen on focal therapies for prostate cancer
FDA approves mitomycin intravesical solution for recurrent LG-IR-NMIBC
Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care
Phase 2 trial of oncolytic immunotherapy launches in BCG-unresponsive NMIBC
En bloc resection of bladder tumor: Is it the way forward?
Ultrasound imaging system now available to guide nonsurgical urology procedures
CPT 49186 vs 38780: Coding retroperitoneal mass excision
CHAI biomarkers demonstrate prognostic utility for high-grade Ta NMIBC